Table 4 Top diseases, molecular, cellular, and physiological functions for differentially expressed genes in PeM compared to BPR
Functions | P-Value | Molecules |
|---|---|---|
Diseases and disorders | ||
Organismal Injury and Abnormalities | 3.22E-02 | CXCL1, EGR1, IL13RA2, NOX4 |
Molecular and Cellular Functions | ||
Carbohydrate Metabolism | 2.19E-02 | ACACB, CRAT, FABP3, GFPT1, NHLRC1, NRG1, NUAK1, PKNOX1, PPARD, PPARG, PRKAA1, PRKAB2, PRKCB, PRKCD, UCP3, UGP2 |
Cellular Growth and Proliferation | 2.18E-02 | ATM, DCN, MSTN, HEY1, MYC, MYF5, PITX2, PRNP |
Small Molecule Biochemistry | 2.19E-02 | CRAT, NRG1, PKNOX1, PPARG, PRKAA1, PRKCD, UCP3 |
Physiological System Development and Function | ||
Skeletal and Muscular System Development and Function - Abnormal Morphology of muscle | 1.89E-02 | CALCRL, CHRNG, COL6A1, CRK, CXCL12, DES, DLG1, ELN, ESR2, FBN1, FN1, FST, HEY1, HLX, INPP5days, KLF2, LMO7, LOX, LPL, MB, MEOX2, MGP, MMP2, MSTN, MTM1, MYF5, NGFR, PITX2, PPARGC1A, SRPK3 |
- Angiogenesis of Skeletal Muscle | 9.22E-03 | CXCL12, MYH9, PPARGC1A, PPARGC1B, VEGFA |
Embryonic Development - Myogenesis of Skeletal Muscle | 1.25E-02 | CAPN3, CSRP3, CXCL12, ELN, GPCPD1, HLX, MEOX2, MSC, MSTN, MYF5, MYH9, PITX2, PPARGC1A, PPARGC1B, RGS2, SIX1, SRPK3, SVIL, UTRN, VEGFA26 |